Skip to main content
SpringerLink
Log in

Cannabis Use Disorder

  • Chapter
  • First Online:
Cannabinoids and Pain

  • 1438 Accesses

Abstract

Adolescents and adults increasingly view cannabis as harmless. While the majority can use cannabis without harm, there are many potential problems including decline in educational or occupational functioning after early adolescent use, impaired driving, cannabis use disorders, cannabis withdrawal, and psychiatric comorbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacology. 2018;43(1):195–212. https://doi.org/10.1038/npp.2017.198.

    Article  PubMed  Google Scholar 

  2. Key substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf. Accessed 28 May 2020.

  3. The 2018 National Survey on Drug Use and Health (NSDUH). https://www.samhsa.gov/data/nsduh/reports-detailed-tables-2018-NSDUH. Accessed 7/8/2019.

  4. Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, Giovino GA, West R, Hall W, Griffiths P, Ali R, Gowing L, Marsden J, Ferrari AJ, Grebely J, Farrell M, Degenhardt L. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–26.

    Article  Google Scholar 

  5. Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219–27.

    Article  Google Scholar 

  6. Wang GS, Roosevelt G, Le Lait MC, Martinez EM, Bucher-Bartelson B, Bronstein AC, Heard K. Association of unintentional pediatric exposures with decriminalization of marijuana in the United States. Ann Emerg Med. 2014;63(6):684–9.

    Article  Google Scholar 

  7. Hasin DS, Saha TD, Kerridge BT, Goldstein RB, et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiat. 2015;72:1235–42.

    Article  Google Scholar 

  8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.

    Book  Google Scholar 

  9. Patel J, Marwaha R. Cannabis use disorder. In: StatPearls. Treasure Island: StatPearls Publishing; 2020.

    Google Scholar 

  10. Bonnet U, Preuss UW. The cannabis withdrawal syndrome: current insights. Subst Abus Rehabil. 2017;8:9–37.

    Article  Google Scholar 

  11. Preuss UW, Watzke AB, Zimmermann J, Wong JW, Schmidt CO. Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients. Drug Alcohol Depend. 2010 Jan 15;106(2–3):133–41.

    Article  CAS  Google Scholar 

  12. Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004 Nov;161(11):1967–77.

    Article  Google Scholar 

  13. Marshall K, Gowing L, Ali R, Le Foll B. Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev. 2014;(12):CD008940.

    Google Scholar 

  14. Trigo JM, Soliman A, Quilty LC, Fischer B, Rehm J, Selby P, Barnes AJ, Huestis MA, George TP, Streiner DL, Staios G, Le Foll B. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: a pilot randomized clinical trial. PLoS One. 2018;13(1):e0190768. https://doi.org/10.1371/journal.pone.0190768.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lintzeris N, Bhardwaj A, Mills L, Dunlop A, Copeland J, McGregor I, Bruno R, Gugusheff J, Phung N, Montebello M, Chan T, Kirby A, Hall M, Jefferies M, Luksza J, Shanahan M, Kevin R, Allsop D, Agonist Replacement for Cannabis Dependence (ARCD) Study Group. Nabiximols for the treatment of cannabis dependence: a randomized clinical trial. JAMA Intern Med. 2019;179(9):1242–53. https://doi.org/10.1001/jamainternmed.2019.1993.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Western Reserve Hospital, Center For Pain Medicine, Cuyahoga Falls, OH, USA

    Samer N. Narouze

  2. Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

    Caroline A. MacCallum

  3. Centre for Addiction and Mental Health, Toronto, ON, Canada

    Lauren de Freitas

Authors
  1. Samer N. Narouze
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline A. MacCallum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lauren de Freitas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samer N. Narouze .

Editor information

Editors and Affiliations

  1. Western Reserve Hospital, Center For Pain Medicine, Cuyahoga Falls, OH, USA

    Samer N. Narouze

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Narouze, S.N., MacCallum, C.A., de Freitas, L. (2021). Cannabis Use Disorder. In: Narouze, S.N. (eds) Cannabinoids and Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-69186-8_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-69186-8_38

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-69185-1

  • Online ISBN: 978-3-030-69186-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation